Cargando…

Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma

In clinical practice, we often deal with patients who suffer from non-alcoholic fatty liver disease (NAFLD) concurrent with type 2 diabetes mellitus (T2DM). The etiopathogenesis of NAFLD is mainly connected with insulin resistance (IR) and obesity. Similarly, the latter patients are in the process o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosmalski, Marcin, Śliwińska, Agnieszka, Drzewoski, Józef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135804/ https://www.ncbi.nlm.nih.gov/pubmed/37189715 http://dx.doi.org/10.3390/biomedicines11041097

Ejemplares similares

Non-Alcoholic Fatty Liver Disease Is Associated with a Decreased Catalase (CAT) Level, CT Genotypes and the T Allele of the -262 C/T CAT Polymorphism
por: Kosmalski, Marcin, et al.
Publicado: (2023)

The Phenotype of Elderly Patients with Type 2 Diabetes Mellitus and Poor Sleep Quality
por: Mikołajczyk-Solińska, Melania, et al.
Publicado: (2020)

Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Tumour protein 53 is linked with type 2 diabetes mellitus
por: Sliwinska, Agnieszka, et al.
Publicado: (2017)

Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy
por: Kasznicki, Jacek, et al.
Publicado: (2012)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
por: Frankowski, Rafał, et al.
Publicado: (2023)

Epigenetic modifications in adipose tissue – relation to obesity and diabetes
por: Kasinska, Marta A., et al.
Publicado: (2015)

The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus—A Cross-Sectional Study
por: Kosmalski, Marcin, et al.
Publicado: (2023)

What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kosmalski, Marcin, et al.
Publicado: (2023)

Dietary Intake of Polyphenols or Polyunsaturated Fatty Acids and Its Relationship with Metabolic and Inflammatory State in Patients with Type 2 Diabetes Mellitus
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Changes in the immune system – the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease
por: Kosmalski, Marcin, et al.
Publicado: (2018)

MicroRNAs and metabolic disorders – where are we heading?
por: Sliwinska, Agnieszka, et al.
Publicado: (2017)

The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders
por: Szymczak-Pajor, Izabela, et al.
Publicado: (2020)

Is p53 Involved in Tissue-Specific Insulin Resistance Formation?
por: Strycharz, Justyna, et al.
Publicado: (2017)

Erratum to “Is p53 Involved in Tissue-Specific Insulin Resistance Formation?”
por: Strycharz, Justyna, et al.
Publicado: (2017)

Dysregulation of Inflammation, Oxidative Stress, and Glucose Metabolism-Related Genes and miRNAs in Visceral Adipose Tissue of Women with Type 2 Diabetes Mellitus
por: Wróblewski, Adam, et al.
Publicado: (2023)

Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2
por: Koullias, Emmanouil S., et al.
Publicado: (2022)

Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds
por: Kosmalski, Marcin, et al.
Publicado: (2023)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease
por: Mandal, Amrendra, et al.
Publicado: (2018)

Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus
por: Olusanya, Titilola Osawaye, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
por: Padda, Jaskamal, et al.
Publicado: (2021)

Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders
por: Wenclewska, Sylwia, et al.
Publicado: (2019)

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
por: Pokharel, Arbinda, et al.
Publicado: (2021)

The chicken and the egg dilemma: A case of disseminated MAC with Hodgkin's lymphoma
por: Varkey, Mary Rithu, et al.
Publicado: (2020)

Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells
por: Sliwinska, Agnieszka, et al.
Publicado: (2011)

The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress
por: Włodarski, Adam, et al.
Publicado: (2020)

Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus
por: Kobayashi, Yukiko, et al.
Publicado: (2016)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
por: Mansour, Asieh, et al.
Publicado: (2023)

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
por: Raff, Evan J., et al.
Publicado: (2015)

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population
por: Rabiee, Behnam, et al.
Publicado: (2017)

Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus
por: Chen, Kaina, et al.
Publicado: (2020)

MON-644 Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
por: Fanous, Nada, et al.
Publicado: (2020)

Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
por: Luo, Yu, et al.
Publicado: (2023)

Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
por: Tsai, Hui-Ju, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
por: Lee, Byung-Wan, et al.
Publicado: (2020)

Single-Nucleotide Polymorphisms in Base-Excision Repair-Related Genes Involved in the Risk of an Occurrence of Non-Alcoholic Fatty Liver Disease
por: Ziółkowska, Sylwia, et al.
Publicado: (2023)

Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis
por: Amiri Dash Atan, Nasrin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tm0s12dm62kk9sooog984bl13f